Κ-opioid receptor - an overview | ScienceDirect Topics
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
The Kappa Opioid Receptor | SpringerLink
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Effects of the kappa opioid receptor agonist nalfurafine on IFN-γ⁺CD4⁺... | Download Scientific Diagram
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
κ-opioid receptor - Wikipedia
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
κ-opioid receptor - Wikipedia
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Opioids in cancer: The κ‑opioid receptor (Review)
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
κ-Opioid Receptor (KOP) | 7TM Antibodies
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Innovation – Cara Therapeutics
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
